You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CTCL

Showing 126 - 150 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphoma Trial in United States (Bortezomib, Romidepsin)

Completed
  • Leukemia
  • Lymphoma
  • Chicago, Illinois
  • +4 more
Apr 19, 2018

Cutaneous T-Cell Lymphoma Trial in Boston (Everolimus)

Terminated
Has Results
  • Cutaneous T-Cell Lymphoma
  • Boston, Massachusetts
    Boston Medical Center
Nov 25, 2016

Von Hippel-Lindau Disease Trial run by the NINDS (Vorinostat)

Completed
  • Von Hippel-Lindau Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 13, 2018

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7, Stage II Mycosis

Completed
Has Results
  • Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Detroit, Michigan
  • +3 more
Apr 23, 2018

Lymphoma Trial in United States (Targretin® (bexarotene), pegylated liposomal doxorubicin HCl)

Completed
Has Results
  • Lymphoma
  • Targretin® (bexarotene)
  • pegylated liposomal doxorubicin hydrochloride
  • Hackensack, New Jersey
  • +4 more
Jul 19, 2018

Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)

Completed
Has Results
  • Hodgkin's Disease
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Center for Lymphoid Malignancies at CUMC
Nov 5, 2020

T-cell Lymphomas, T-cell Leukemia, Sezary Syndrome Trial in United States (A-dmDT390-bisFv(UCHT1))

Completed
  • T-cell Lymphomas
  • +4 more
  • A-dmDT390-bisFv(UCHT1)
  • New Haven, Connecticut
  • +4 more
Nov 28, 2016

Leukemia, MDS, Myelodysplastic/Myeloproliferative Diseases Trial in Baltimore (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Leukemia
  • +2 more
  • sargramostim
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 7, 2018

Lymphoma Trial in Houston (CD5789 0.01% Cream)

Completed
  • Lymphoma
  • CD5789 0.01% Cream
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 11, 2016

Long-term Use of Romidepsin in Patients With CTCL

Completed
  • Cutaneous T-cell Lymphoma
  • Chicago, Illinois
    Northwestern University Dermatology Department
Mar 10, 2016

Lymphoma, T-Cell Trial in Ann Arbor (MLN9708)

Completed
Has Results
  • Lymphoma, T-Cell
  • Ann Arbor, Michigan
    University of Michigan Hospital
Oct 10, 2017

Lymphoma, T-cell, Peripheral Trial in Japan (Romidepsin)

Completed
Has Results
  • Lymphoma, T-cell, Peripheral
  • Nagoya, Aichi, Japan
  • +16 more
Jan 28, 2019

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)

Completed
Has Results
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Scottsdale, Arizona
  • +12 more
Apr 13, 2017

Leukemia, Lymphocytic, Chronic Trial run by the NCI (LMB-2)

Completed
Has Results
  • Leukemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 27, 2017

VircapSeq Virus Detection in Sézary Syndrome

Completed
  • Lymphoma, T-Cell, Cutaneous
  • Sézary Syndrome
    • New York, New York
      Columbia University Medical Center
    Feb 6, 2017

    Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides Trial (MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA)

    Completed
    • Cutaneous T-cell Lymphoma
    • +2 more
    • MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) / Duration of Treatment 6 Months
    • (no location specified)
    Apr 3, 2017

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Buffalo (LBH589)

    Terminated
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 11, 2017

    Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides and Sezary Syndrome, Stage IIB Mycosis Fungoides and Sezary

    Withdrawn
    • Cutaneous T-Cell Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 17, 2017

    Mycosis Fungoides Trial (A-dmDT390-bisFv(UCHT1), Vorinostat)

    Unknown status
    • Mycosis Fungoides
    • (no location specified)
    Oct 21, 2016

    Lymphoma Trial (vorinostat)

    Completed
    Has Results
    • Lymphoma
    • (no location specified)
    Apr 2, 2015

    Lymphoma, B-Cell, T-Cell Lymphoma Trial in Paris, Milano (RP6530)

    Completed
    • Lymphoma, B-Cell
    • T-Cell Lymphoma
    • Paris, France
    • +2 more
    Jun 23, 2016

    Advanced Cancers, Solid Tumors Trial in Houston (Erlotinib, Pralatrexate)

    Completed
    • Advanced Cancers
    • Solid Tumors
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jul 1, 2016

    Lymphoma Trial (bortezomib, vorinostat, laboratory biomarker analysis)

    Withdrawn
    • Lymphoma
    • (no location specified)
    Jan 20, 2015

    Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (belinostat)

    Terminated
    Has Results
    • Cutaneous T-Cell Lymphoma
    • +2 more
    • Stanford, California
    • +14 more
    Jul 7, 2015

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial in Melbourne (Eltrombopag and Vorinostat)

    Terminated
    • Follicular Lymphoma
    • +2 more
    • Eltrombopag and Vorinostat
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Feb 12, 2016